Female Sexual Dysfunction Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: F29060A1340CEN
Market Monitor Global

Abstracts

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.

This report contains market size and forecasts of Female Sexual Dysfunction Treatment in Global, including the following market information:

Global Female Sexual Dysfunction Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Female Sexual Dysfunction Treatment market was valued at 126.1 million in 2021 and is projected to reach US$ 762.6 million by 2028, at a CAGR of 29.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-hormonal Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Female Sexual Dysfunction Treatment include AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Novo Nordisk AS and Sprout Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Sexual Dysfunction Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Sexual Dysfunction Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Female Sexual Dysfunction Treatment Market Segment Percentages, by Type, 2021 (%)

• Non-hormonal Therapy
• Hormonal Therapy

Global Female Sexual Dysfunction Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Female Sexual Dysfunction Treatment Market Segment Percentages, by Application, 2021 (%)

• Sexual Desire Disorders
• Sexual Arousal Disorders
• Orgasm Disorders
• Sexual Pain Disorders
• Post-orgasmic Diseases
• Pelvic Floor Dysfunction
• Other

Global Female Sexual Dysfunction Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Female Sexual Dysfunction Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Female Sexual Dysfunction Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Female Sexual Dysfunction Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AMAG Pharmaceuticals Inc.
• Duchesnay Inc.
• Emotional Brain BV
• Novo Nordisk AS
• Sprout Pharmaceuticals Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Female Sexual Dysfunction Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Female Sexual Dysfunction Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEMALE SEXUAL DYSFUNCTION TREATMENT OVERALL MARKET SIZE

2.1 Global Female Sexual Dysfunction Treatment Market Size: 2021 VS 2028
2.2 Global Female Sexual Dysfunction Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Female Sexual Dysfunction Treatment Players in Global Market
3.2 Top Global Female Sexual Dysfunction Treatment Companies Ranked by Revenue
3.3 Global Female Sexual Dysfunction Treatment Revenue by Companies
3.4 Top 3 and Top 5 Female Sexual Dysfunction Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Female Sexual Dysfunction Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Female Sexual Dysfunction Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Female Sexual Dysfunction Treatment Market Size Markets, 2021 & 2028
  4.1.2 Non-hormonal Therapy
  4.1.3 Hormonal Therapy
4.2 By Type - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
  4.2.1 By Type - Global Female Sexual Dysfunction Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Female Sexual Dysfunction Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Female Sexual Dysfunction Treatment Market Size, 2021 & 2028
  5.1.2 Sexual Desire Disorders
  5.1.3 Sexual Arousal Disorders
  5.1.4 Orgasm Disorders
  5.1.5 Sexual Pain Disorders
  5.1.6 Post-orgasmic Diseases
  5.1.7 Pelvic Floor Dysfunction
  5.1.8 Other
5.2 By Application - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
  5.2.1 By Application - Global Female Sexual Dysfunction Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Female Sexual Dysfunction Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Female Sexual Dysfunction Treatment Market Size, 2021 & 2028
6.2 By Region - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
  6.2.1 By Region - Global Female Sexual Dysfunction Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Female Sexual Dysfunction Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Female Sexual Dysfunction Treatment Revenue, 2017-2028
  6.3.2 US Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.3.3 Canada Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.3.4 Mexico Female Sexual Dysfunction Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Female Sexual Dysfunction Treatment Revenue, 2017-2028
  6.4.2 Germany Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.3 France Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.4 U.K. Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.5 Italy Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.6 Russia Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.4.8 Benelux Female Sexual Dysfunction Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Female Sexual Dysfunction Treatment Revenue, 2017-2028
  6.5.2 China Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.5.3 Japan Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.5.4 South Korea Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.5.6 India Female Sexual Dysfunction Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Female Sexual Dysfunction Treatment Revenue, 2017-2028
  6.6.2 Brazil Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.6.3 Argentina Female Sexual Dysfunction Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, 2017-2028
  6.7.2 Turkey Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.7.3 Israel Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Female Sexual Dysfunction Treatment Market Size, 2017-2028
  6.7.5 UAE Female Sexual Dysfunction Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AMAG Pharmaceuticals Inc.
  7.1.1 AMAG Pharmaceuticals Inc. Corporate Summary
  7.1.2 AMAG Pharmaceuticals Inc. Business Overview
  7.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Major Product Offerings
  7.1.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.1.5 AMAG Pharmaceuticals Inc. Key News
7.2 Duchesnay Inc.
  7.2.1 Duchesnay Inc. Corporate Summary
  7.2.2 Duchesnay Inc. Business Overview
  7.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Major Product Offerings
  7.2.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.2.5 Duchesnay Inc. Key News
7.3 Emotional Brain BV
  7.3.1 Emotional Brain BV Corporate Summary
  7.3.2 Emotional Brain BV Business Overview
  7.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Major Product Offerings
  7.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.3.5 Emotional Brain BV Key News
7.4 Novo Nordisk AS
  7.4.1 Novo Nordisk AS Corporate Summary
  7.4.2 Novo Nordisk AS Business Overview
  7.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Major Product Offerings
  7.4.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novo Nordisk AS Key News
7.5 Sprout Pharmaceuticals Inc.
  7.5.1 Sprout Pharmaceuticals Inc. Corporate Summary
  7.5.2 Sprout Pharmaceuticals Inc. Business Overview
  7.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Major Product Offerings
  7.5.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.5.5 Sprout Pharmaceuticals Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Female Sexual Dysfunction Treatment Market Opportunities & Trends in Global Market
Table 2. Female Sexual Dysfunction Treatment Market Drivers in Global Market
Table 3. Female Sexual Dysfunction Treatment Market Restraints in Global Market
Table 4. Key Players of Female Sexual Dysfunction Treatment in Global Market
Table 5. Top Female Sexual Dysfunction Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Female Sexual Dysfunction Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Female Sexual Dysfunction Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Female Sexual Dysfunction Treatment Product Type
Table 9. List of Global Tier 1 Female Sexual Dysfunction Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Female Sexual Dysfunction Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Female Sexual Dysfunction Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AMAG Pharmaceuticals Inc. Corporate Summary
Table 31. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 32. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Duchesnay Inc. Corporate Summary
Table 34. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 35. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Emotional Brain BV Corporate Summary
Table 37. Emotional Brain BV Female Sexual Dysfunction Treatment Product Offerings
Table 38. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novo Nordisk AS Corporate Summary
Table 40. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offerings
Table 41. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sprout Pharmaceuticals Inc. Corporate Summary
Table 43. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 44. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Female Sexual Dysfunction Treatment Segment by Type in 2021
Figure 2. Female Sexual Dysfunction Treatment Segment by Application in 2021
Figure 3. Global Female Sexual Dysfunction Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Female Sexual Dysfunction Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Female Sexual Dysfunction Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Sexual Dysfunction Treatment Revenue in 2021
Figure 8. By Type - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 12. US Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 24. China Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)